WS17.6 Phase 3 trial of inhaled levofloxacin (Aeroquin™, MP-376, APT-1026) vs. tobramycin inhalation solution (TIS) in intensively treated CF patients over 6 months

• DOI: 10.1016/s1569-1993(13)60108-3
• Publication Date: 2013-06-05T15:18:32Z
• Authors: J.S. Elborn; D. Geller; D. Conrad; S. Aaron; A.R. Smyth; R. Fischer; E. Kerem; S.C. Bell; J. Loutit; P. Flume
• Keywords: Pulmonary and Respiratory Medicine; 03 medical and health sciences; 0302 clinical medicine; Pediatrics, Perinatology, and Child Health